与Traf2和NcK相互作用的激酶抑制剂NCB-0846抑制了包括GRIA1降低在内的活动
Min Wang1, Yixue Gu2, Qiubo Li3
1Department of Neurology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, China.
Genes & diseases
|January 31, 2024
概括
在中,Traf2和NcK相互作用激酶 (TNIK) 表达减少. 在模型中,用NCB-0846抑制TNIK降低了发作的严重程度和进展,这表明TNIK是潜在的抗药物标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种常见的神经系统疾病,其特点是经常性发作.
- 叶 (TLE) 是一种常见的医学上难以治疗的形式.
- 目前,Traf2和NcK相互作用激酶 (TNIK) 在中的作用尚不清楚.
研究的目的:
- 为了研究TNIK在中的表达.
- 在模型中探索TNIK抑制剂NCB-0846的治疗潜力.
- 为了阐明TNIK参与的潜在分子机制.
主要方法:
- 西方涂抹,免疫光和免疫组织化学被用于评估TLE患者的TNIK表达和皮洛卡尔诱导的老鼠模型.
- 使用基 (PTZ) 诱导的鼠模型来评估 NCB-0846 的影响.
- 同免疫沉 (Co-IP) /质谱 (MS) 和亚细胞分离确定了TNIK相互作用体,并评估了NCB-0846对 postsynaptic密度 (PSD) 蛋白的影响.
主要成果:
- 与对照组相比,TNIK表达在模型大鼠和TLE患者中显著下降.
- 在PTZ诱导模型中,NCB-0846治疗延迟了点燃进展,并降低了发作的严重程度.
- 联合IP/MS确定了63个候选TNIK相互作用器,包括CaMKII. TNIK与GRIA1,SYN2,PSD-95,CaMKIV,GABRG1 和 GABRG2.2 相对应的结果. NCB-0846治疗降低了海马溶解物和PSD中的GRIA1水平.
结论:
- 在中,TNIK的表达减少,这表明它参与了病理学.
- TNIK 抑制剂 NCB-0846 通过调节活动和进展,显示出作为抗药物的潜力.
- TNIK与GRIA1等关键突触蛋白的相互作用可能是其在中的作用的基础,提供了一个新的治疗标.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
303
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
303
Antiepileptic Drugs: GABAergic Pathway Potentiators
403
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
403
Antiepileptic Drugs: Calcium Channel Blockers
403
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
403
Antiepileptic Drugs: Glutamate Antagonists
359
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
359
Antiepileptic Drugs: Sodium Channel Blockers
567
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
567


